Clover Health Investments, Corp. (CLOV) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	2.5B	1.9B	1.4B	1.3B	1.1B
Cost of Revenue	2.0B	1.6B	1.0B	1.0B	993.1M
Gross Profit	459.9M	355.9M	364.8M	256.0M	103.5M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	213.0M	176.3M	408.9M	440.2M	482.4M
General & Admin Expense	213.0M	176.3M	408.9M	440.2M	482.4M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	265.3M	265.1M	1.6M	21.0M	(92.3M)
Total Operating Expenses	478.3M	441.4M	410.6M	461.3M	390.1M
Cost and Expenses	2.5B	2.0B	1.4B	1.5B	1.4B
Operating Income (EBIT)	(18.4M)	(85.5M)	(45.7M)	(205.3M)	(286.7M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	7.0K	1.4M
Net Interest Income	—	—	—	(7.0K)	(1.4M)
Other Non-Op Income/Expense	(1.0K)	(20.0K)	(517.0K)	(4.8M)	32.1M
Non-Operating Income (excl Interest)	1.0K	20.0K	517.0K	4.8M	(33.4M)
EBT (Pre-Tax Income)	(18.4M)	(85.5M)	(46.3M)	(210.1M)	(254.6M)
Income Tax Expense	—	—	—	—	—
Bottom Line
Net Income	(18.4M)	(85.5M)	(43.0M)	(213.4M)	(339.6M)
Earnings from Cont. Ops	(18.4M)	(85.5M)	(46.3M)	(210.1M)	(254.6M)
Earnings from Discont. Ops	—	—	3.3M	(3.2M)	(85.0M)
Bottom Line Net Income	(18.4M)	(85.5M)	(43.0M)	(213.4M)	(339.6M)
Per Share
Basic EPS	($0.04)	($0.17)	($0.09)	($0.45)	($0.71)
Diluted EPS	($0.04)	($0.17)	($0.09)	($0.45)	($0.71)
Revenue Per Share	$4.72	$3.72	$2.80	$2.61	$2.30
Shares
Basic Shares Outstanding	524.2M	517.2M	490.0M	482.2M	476.2M
Diluted Shares Outstanding	545.4M	517.2M	490.0M	482.2M	476.2M
Profitability Metrics
EBITDA	(16.5M)	(83.9M)	(44.9M)	(207.6M)	(252.0M)
D&A	1.9M	1.7M	1.3M	2.5M	1.2M
EBIT	(18.4M)	(85.5M)	(46.3M)	(210.1M)	(253.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026